Picotamide

DB13327ExperimentalSmall molecule

Picotamide is a platelet aggregation inhibitor indicated in the treatment of myocardial infarction, thrombosis, cerebrovascular disorders, pulmonary emboli, and atherosclerosis. A medication used to treat conditions caused by blood clots.

Mechanism: Pharmacologically active on Thromboxane A2 receptor and Thromboxane-A synthase
Curator reviewed
Formula / weight: C₂₁H₂₀N₄O₃ · 376.416 g/mol (avg)

Resolves to

Compound

UNII654G2VCI4QCAS32828-81-2ChEMBLCHEMBL1257015ChEBI93175

Clinical / RWD

ATCB01AC03

Structure

InChIKeyKYWCWBXGRWWINE-UHFFFAOYSA-NSMILESCOC1=CC=C(C=C1C(=O)NCC1=CC=CN=C1)C(=O)NCC1=CC=CN=C1

Targets

P21731TBXA2RP24557TBXAS1

What you can answer from here — as of June 15, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

420Drug interactionsStructured to mechanism, not free text

7Structured indicationsCondition, population, route and combination as fields, not prose

4ContraindicationsEach with its own population and attribute set

1Marketed productAcross 1 country and 1 labeller

1ATC codeIncluding every combination product, plus 5 drug categories

5+ReferencesStructured and connected to the statements they support

Which drugs share a target with Picotamide, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Log In Paid Account Log In